{"id":"https://openalex.org/W7166178680","doi":"https://doi.org/10.1136/bmjgast-2026-002347","title":"Anti-TNF immunogenicity in a Middle Eastern inflammatory bowel disease cohort: prevalence, predictors and context-specific drug level thresholds","display_name":"Anti-TNF immunogenicity in a Middle Eastern inflammatory bowel disease cohort: prevalence, predictors and context-specific drug level thresholds","publication_year":2026,"publication_date":"2026-06-01","ids":{"openalex":"https://openalex.org/W7166178680","doi":"https://doi.org/10.1136/bmjgast-2026-002347","pmid":"https://pubmed.ncbi.nlm.nih.gov/42362204","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13311678"},"language":"en","primary_location":{"id":"doi:10.1136/bmjgast-2026-002347","doi":"https://doi.org/10.1136/bmjgast-2026-002347","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjgast-2026-002347","pdf_url":"https://bmjopengastro.bmj.com/content/13/1/e002347.full.pdf","source":{"id":"https://openalex.org/S2764956485","display_name":"BMJ Open Gastroenterology","issn_l":"2054-4774","issn":["2054-4774"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmjopengastro.bmj.com/content/13/1/e002347.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102751707","display_name":"Shaima Wasim Khan","orcid":"https://orcid.org/0009-0001-8201-8663","observed_orcids":["https://orcid.org/0009-0001-8201-8663"]},"institutions":[{"id":"https://openalex.org/I4210093832","display_name":"Sheikh Shakhbout Medical City","ror":"https://ror.org/00gk5fa11","country_code":"AE","type":"healthcare","lineage":["https://openalex.org/I4210093832"]}],"countries":["AE"],"is_corresponding":false,"raw_author_name":"Shaima Wasim Khan","raw_affiliation_strings":["Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE"],"raw_orcid":"https://orcid.org/0009-0001-8201-8663","affiliations":[{"raw_affiliation_string":"Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE","institution_ids":["https://openalex.org/I4210093832"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136511099","display_name":"Noorah Al Hosani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093832","display_name":"Sheikh Shakhbout Medical City","ror":"https://ror.org/00gk5fa11","country_code":"AE","type":"healthcare","lineage":["https://openalex.org/I4210093832"]}],"countries":["AE"],"is_corresponding":false,"raw_author_name":"Noorah Al Hosani","raw_affiliation_strings":["Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE","institution_ids":["https://openalex.org/I4210093832"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100799925","display_name":"Thaer Khaleel Swaid","orcid":"https://orcid.org/0009-0009-1969-5125","observed_orcids":["https://orcid.org/0009-0009-1969-5125"]},"institutions":[{"id":"https://openalex.org/I4210093832","display_name":"Sheikh Shakhbout Medical City","ror":"https://ror.org/00gk5fa11","country_code":"AE","type":"healthcare","lineage":["https://openalex.org/I4210093832"]}],"countries":["AE"],"is_corresponding":false,"raw_author_name":"Thaer Khaleel Swaid","raw_affiliation_strings":["Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE","institution_ids":["https://openalex.org/I4210093832"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114451828","display_name":"Mazin M Edan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093832","display_name":"Sheikh Shakhbout Medical City","ror":"https://ror.org/00gk5fa11","country_code":"AE","type":"healthcare","lineage":["https://openalex.org/I4210093832"]}],"countries":["AE"],"is_corresponding":false,"raw_author_name":"Mazin M Edan","raw_affiliation_strings":["Department of Internal Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, UAE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, UAE","institution_ids":["https://openalex.org/I4210093832"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110455218","display_name":"Mohammed Nabil Quraishi","orcid":"https://orcid.org/0009-0004-1673-7792","observed_orcids":["https://orcid.org/0009-0004-1673-7792"]},"institutions":[{"id":"https://openalex.org/I176601375","display_name":"Khalifa University of Science and Technology","ror":"https://ror.org/05hffr360","country_code":"AE","type":"education","lineage":["https://openalex.org/I176601375"]},{"id":"https://openalex.org/I4210093832","display_name":"Sheikh Shakhbout Medical City","ror":"https://ror.org/00gk5fa11","country_code":"AE","type":"healthcare","lineage":["https://openalex.org/I4210093832"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["AE","GB"],"is_corresponding":true,"raw_author_name":"Mohammed Nabil Quraishi","raw_affiliation_strings":["College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi, UAE","Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE","Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK"],"raw_orcid":"https://orcid.org/0009-0004-1673-7792","affiliations":[{"raw_affiliation_string":"College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi, UAE","institution_ids":["https://openalex.org/I176601375"]},{"raw_affiliation_string":"Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE","institution_ids":["https://openalex.org/I4210093832"]},{"raw_affiliation_string":"Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5110455218"],"corresponding_institution_ids":["https://openalex.org/I176601375","https://openalex.org/I4210093832","https://openalex.org/I79619799"],"apc_list":{"value":1700,"currency":"GBP","value_usd":2085},"apc_paid":{"value":1700,"currency":"GBP","value_usd":2085},"fwci":8.168,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.97398733,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":97},"biblio":{"volume":"13","issue":"1","first_page":"e002347","last_page":"e002347"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.8980000019073486},{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.9819999933242798},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9440000057220459},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":1.0},{"id":"https://openalex.org/keywords/loss-of-response","display_name":"loss of response","score":0.7670000195503235},{"id":"https://openalex.org/keywords/prior-surgery","display_name":"prior surgery","score":0.5419999957084656},{"id":"https://openalex.org/keywords/subcutaneous-infliximab","display_name":"subcutaneous infliximab","score":0.8980000019073486},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.5450000166893005},{"id":"https://openalex.org/keywords/middle-eastern-patients","display_name":"Middle Eastern patients","score":0.6970000267028809},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.4690000116825104},{"id":"https://openalex.org/keywords/propensity-score-matching","display_name":"propensity score matching","score":0.5509999990463257},{"id":"https://openalex.org/keywords/propensity-score-stratification","display_name":"propensity score stratification","score":0.39100000262260437}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9090999960899353},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.9007999897003174},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.8626000285148621},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.8421000242233276},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6937000155448914},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6251000165939331},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.49720001220703125},{"id":"https://openalex.org/C31785415","wikidata":"https://www.wikidata.org/wiki/Q7846541","display_name":"Trough level","level":4,"score":0.47600001096725464},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.43470001220703125},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4246000051498413},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4219000041484833},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38119998574256897},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.37470000982284546},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.3693999946117401},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.3336000144481659},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3199000060558319},{"id":"https://openalex.org/C58471807","wikidata":"https://www.wikidata.org/wiki/Q327120","display_name":"Receiver operating characteristic","level":2,"score":0.3156000077724457},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.30979999899864197},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.30390000343322754},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.30140000581741333},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.29679998755455017},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.2912999987602234},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.2630000114440918},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.2542000114917755},{"id":"https://openalex.org/C2776207728","wikidata":"https://www.wikidata.org/wiki/Q7918002","display_name":"Vedolizumab","level":4,"score":0.25290000438690186}],"mesh":[{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005765","descriptor_name":"Gastrointestinal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005765","descriptor_name":"Gastrointestinal Agents","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D005765","descriptor_name":"Gastrointestinal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012372","descriptor_name":"ROC Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D014479","descriptor_name":"United Arab Emirates","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015212","descriptor_name":"Inflammatory Bowel Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015212","descriptor_name":"Inflammatory Bowel Diseases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1136/bmjgast-2026-002347","doi":"https://doi.org/10.1136/bmjgast-2026-002347","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjgast-2026-002347","pdf_url":"https://bmjopengastro.bmj.com/content/13/1/e002347.full.pdf","source":{"id":"https://openalex.org/S2764956485","display_name":"BMJ Open Gastroenterology","issn_l":"2054-4774","issn":["2054-4774"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open Gastroenterology","raw_type":"journal-article"},{"id":"pmid:42362204","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42362204","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ open gastroenterology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13311678","doi":null,"is_oa":true,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42362204/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open Gastroenterol","raw_type":"Text"},{"id":"pmh:oai:pure.atira.dk:openaire/385eea6a-7af1-430f-b825-e20899c3557d","doi":null,"is_oa":true,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/385eea6a-7af1-430f-b825-e20899c3557d","pdf_url":"https://pure-oai.bham.ac.uk/ws/files/309315610/KhanSW2026AntiTNF.pdf","source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Khan, S W, Al Hosani, N, Swaid, T K, Edan, M M & Quraishi, M N 2026, 'Anti-TNF immunogenicity in a Middle Eastern inflammatory bowel disease cohort : prevalence, predictors and context-specific drug level thresholds', BMJ Open Gastroenterology, vol. 13, no. 1, e002347. https://doi.org/10.1136/bmjgast-2026-002347","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:e41799289a6940e787ba02e91a69097d","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/e41799289a6940e787ba02e91a69097d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMJ Open Gastroenterology, Vol 13, Iss 1 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/bmjgast-2026-002347","doi":"https://doi.org/10.1136/bmjgast-2026-002347","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjgast-2026-002347","pdf_url":"https://bmjopengastro.bmj.com/content/13/1/e002347.full.pdf","source":{"id":"https://openalex.org/S2764956485","display_name":"BMJ Open Gastroenterology","issn_l":"2054-4774","issn":["2054-4774"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open Gastroenterology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7166178680.pdf","grobid_xml":"https://content.openalex.org/works/W7166178680.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W1997999969","https://openalex.org/W2003835888","https://openalex.org/W2040157712","https://openalex.org/W2040181440","https://openalex.org/W2056586250","https://openalex.org/W2064485014","https://openalex.org/W2064877889","https://openalex.org/W2071538770","https://openalex.org/W2071885860","https://openalex.org/W2099169909","https://openalex.org/W2115112939","https://openalex.org/W2164558952","https://openalex.org/W2171297959","https://openalex.org/W2171341132","https://openalex.org/W2171600077","https://openalex.org/W2541768017","https://openalex.org/W2586142976","https://openalex.org/W2744879509","https://openalex.org/W2766046358","https://openalex.org/W2916794721","https://openalex.org/W2923576761","https://openalex.org/W3134678138","https://openalex.org/W4229369896","https://openalex.org/W4292341189","https://openalex.org/W4293536498","https://openalex.org/W4311024742","https://openalex.org/W4321997017","https://openalex.org/W4390858464","https://openalex.org/W4392133996","https://openalex.org/W4392143386","https://openalex.org/W4394859940","https://openalex.org/W4398255413","https://openalex.org/W4401793442","https://openalex.org/W4401799841","https://openalex.org/W4401895894","https://openalex.org/W4406780583","https://openalex.org/W4409907206","https://openalex.org/W4412687296","https://openalex.org/W4415942851","https://openalex.org/W4416902579","https://openalex.org/W4417496967"],"related_works":["https://openalex.org/W2914254130","https://openalex.org/W3213047483","https://openalex.org/W3167367183","https://openalex.org/W4406687641","https://openalex.org/W4322716087","https://openalex.org/W7211893482","https://openalex.org/W4283689701","https://openalex.org/W4205534028","https://openalex.org/W2806588875","https://openalex.org/W4416235025"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Anti-tumour":[1],"necrosis":[2],"factor":[3],"(anti-TNF)":[4],"immunogenicity":[5,27,171,216],"remains":[6],"a":[7,36,57,73,247,278],"major":[8],"barrier":[9],"to":[10,107,191,209],"treatment":[11,47],"persistence":[12],"in":[13,35,53,60,94,138,259],"inflammatory":[14],"bowel":[15],"disease,":[16],"yet":[17],"data":[18],"from":[19],"Middle":[20,261],"Eastern":[21,262],"populations":[22],"are":[23,264],"lacking.":[24],"We":[25],"characterised":[26],"rates,":[28],"predictors":[29,83],"and":[30,84,114,163,286],"loss":[31,85],"of":[32,86,97,102,129,152,281],"response":[33,87],"mechanisms":[34,88],"real-world":[37],"cohort.":[38],"METHODS:":[39],"This":[40],"retrospective":[41],"cohort":[42,263],"study":[43],"included":[44],"314":[45],"anti-TNF":[46],"courses":[48,98,140],"(212":[49],"infliximab,":[50],"102":[51],"adalimumab)":[52],"248":[54],"patients":[55,199],"at":[56],"tertiary":[58],"centre":[59],"the":[61,126,159,183,201,238],"United":[62],"Arab":[63],"Emirates.":[64],"Immunogenicity":[65,92,257],"was":[66,125,182],"defined":[67],"by":[68],"detectable":[69],"anti-drug":[70],"antibodies":[71],"on":[72,235],"drug-tolerant":[74],"electrochemiluminescent":[75],"bridging":[76],"immunoassay":[77],"with":[78,172,266],"acid":[79],"dissociation.":[80],"Drug":[81],"levels,":[82],"were":[89,135],"analysed.":[90],"RESULTS:":[91],"developed":[93],"28.3%":[95],"(89/314)":[96],"over":[99],"median":[100],"follow-up":[101],"24.0":[103],"months":[104],"(median":[105,141],"time":[106],"detection":[108],"15.0":[109],"months,":[110],"IQR":[111],"8.0-36.0).":[112],"Infliximab":[113],"adalimumab":[115,167],"had":[116],"comparable":[117],"rates":[118],"(26.9%":[119],"vs":[120,143,227,243],"31.4%;":[121],"p=0.425).":[122],"Immunogenicity-mediated":[123],"failure":[124],"leading":[127],"cause":[128],"discontinuation":[130],"(48.4%).":[131],"Pre-event":[132],"trough":[133],"levels":[134],"significantly":[136],"lower":[137,215],"immunogenic":[139,293],"3.0":[142],"14.0":[144],"mcg/mL;":[145],"p<0.001).":[146],"Exploratory":[147],"receiver":[148],"operating":[149],"characteristic":[150],"thresholds":[151],"5.3":[153],"mcg/mL":[154,165],"for":[155,166],"infliximab":[156,213,219,289],"(area":[157],"under":[158],"curve":[160],"(AUC)":[161],"0.880)":[162],"6.4":[164],"(AUC":[168],"0.861)":[169],"predicted":[170],"high":[173],"discrimination.":[174],"On":[175],"shared":[176],"frailty":[177],"Cox":[178],"regression,":[179],"prior":[180],"surgery":[181,202],"strongest":[184],"predictor":[185],"(HR":[186,204],"1.85,":[187],"95%":[188,206],"CI":[189,207],"0.94":[190],"3.64;":[192],"p=0.074).":[193],"A":[194],"sensitivity":[195],"analysis":[196,250],"excluding":[197],"rescued":[198],"strengthened":[200],"signal":[203],"2.80,":[205],"1.41":[208],"5.56;":[210],"p=0.003).":[211],"Subcutaneous":[212],"showed":[214],"than":[217,272],"intravenous":[218],"(new":[220],"starters":[221],"1/25":[222],"(4.0%),":[223],"switchers":[224],"1/33":[225],"(3.0%)":[226],"IV":[228],"57/212":[229],"(26.9%));":[230],"after":[231],"propensity":[232],"score":[233],"matching":[234],"five":[236],"covariates,":[237],"difference":[239],"remained":[240],"significant":[241],"(3.8%":[242],"18.3%;":[244],"p=0.013),":[245],"though":[246],"new":[248],"starters-only":[249],"did":[251],"not":[252],"reach":[253],"significance":[254],"(p=0.062).":[255],"CONCLUSION:":[256],"patterns":[258],"this":[260],"consistent":[265],"Western":[267],"data,":[268],"supporting":[269],"pharmacokinetic":[270],"rather":[271],"population-specific":[273],"determinants.":[274],"These":[275],"findings":[276],"suggest":[277],"potential":[279],"benefit":[280],"proactive":[282],"therapeutic":[283],"drug":[284],"monitoring":[285],"that":[287],"subcutaneous":[288],"may":[290],"offer":[291],"an":[292],"advantage":[294],"warranting":[295],"prospective":[296],"validation.":[297]},"counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-06-27T00:00:00"}